• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/92

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

92 Cards in this Set

  • Front
  • Back
Powdered Infant Formula
milk based
Enterobacter sakazakii infection
Infection of blood and central nerve in neonates and infants
Enterobacter sakazakii infection
sepsis, meningities, necrotizing enterocolitis
Enterobacter sakazakii infection
Infants <28 days
Enterobacter sakazakii infection
ubiquitous
Enterobacter sakazakii infection
bacterium found in milk, herbs/spices, meat sausages, baby foods, vegetables
Enterobacter sakazakii infection
Symptoms : seizures, brain abscess, hydrocephalus, developmental delay and death
Enterobacter sakazakii infection
33- 80 % infant infected die
Enterobacter sakazakii infection
Treatment: combination of ampicillin with gentamicin or chloraamphenical
Developed resistance to ampicillin
Enterobacter sakazakii infection
Gram -ve rod,
Enterobacteriaceae family
Enterobacter sakazakii infection
Bacterium thermotolerant
Enterobacter sakazakii infection
minimum growth 6
optimal 37- 43
Enterobacter sakazakii infection
exact virulence unknown
Enterobacter sakazakii infection
bacterium could attached host cells and survive inside macrophage
Enterobacter sakazakii infection
Produce capsule materials
help survive environment
Enterobacter sakazakii infection
Attached to silicon and plastic surface
Enterobacter sakazakii infection
Form biofilm which is difficult to remoce
Enterobacter sakazakii infection
Lethal dose 10^5 to 10 ^ 8 cells
Enterobacter sakazakii infection
contaminated during manufacturing
Enterobacter sakazakii infection
contaminated during infant formula preparation , eg utensil , spoon
Enterobacter sakazakii infection
Powdered milk is not sterilized
found in PIF 0.36- 66 CFU per 100g
Enterobacter sakazakii infection
suitable breast milk substitue
accordance with the codex alimentarius commission standard
Enterobacter sakazakii infection
abdominal and bowel symptoms that occur with sufficient frequency in affected patients.
Irritable Bowel Syndrome
symptoms : abdominal pain, bloating and bowel disturbance ( constipation or diarrhea)
Irritable Bowel Syndrome
etiology: multifactor
hypersensitivity
stress
gut microflora alteration
Irritable Bowel Syndrome
small intestine bacterial overgrowth
Irritable Bowel Syndrome
increasing numbers
populations changes
Irritable Bowel Syndrome
More Gram +ve bacteria
Bacteroides, Streptococcus, Lactobavillus
Irritable Bowel Syndrome
Gram - ve Escherichia
Irritable Bowel Syndrome
Stay ill for 5 years
Irritable Bowel Syndrome
Treatment: Broad Spectrum antibiotics - temporary effect
Irritable Bowel Syndrome
Probiotic treatment:
Bifdobacterium reduced abnormal inflammation
Irritable Bowel Syndrome
developed due to previous infectious gastroenteritis
Post Infection IBS
possible organisms: Camplylobacter, Salmonella, Shigella
Post Infection IBS
Campylobacter jejuni -stimulate infiltration of enterochromaffin (EC) and lymphocyte cells
Post Infection IBS
more frequent in young female
Post Infection IBS
Campylobacter jejun
stimulate infiltration of enterochromaffin (EC) and lymphocyte cells
Post Infections IBS
increased gut permeability and inflammation
Post Infection IBS
increased EC cells, CD3 lymphocytes and macrophage IL1
Post Infection IBS
abnormal seretonin metabolism, increased 5- HT ( 5 hydroxytryptamine)
Post Infection IBS
bacterial gastroenteritis
Post Infection IBS
Occurs after a gastrointestinal infection with enterohemarrhagic Escherichia coli
Hemolytic Uremic Syndrome (HUS)
Most common in children under 5 years old
Hemolytic Uremic Syndrome (HUS)
Leading cause of acute renal failure in children
Hemolytic Uremic Syndrome (HUS)
Monitored by Foodnet
Hemolytic Uremic Syndrome (HUS)
Symptoms : early - vomiting, bloody diarrhea, weakness, irritability
Hemolytic Uremic Syndrome (HUS)
Symptoms: later- low or no urine output, Blood in urine, anemia, loss of consciousness, high blood pressure
Hemolytic Uremic Syndrome (HUS)
Mortality rate 5 - 15%
Hemolytic Uremic Syndrome (HUS)
Treatment: Dialysis
Medications such as corticosteroids
Hemolytic Uremic Syndrome (HUS)
Transfusions of red blood cells and platelets
Hemolytic Uremic Syndrome (HUS)
Primary EHEC serotype is O157: H7
Hemolytic Uremic Syndrome (HUS)
other bacteria : salmonella shigella
other than O157
Hemolytic Uremic Syndrome (HUS)
Primary virulence factor is shiga toxin
Hemolytic Uremic Syndrome (HUS)
Shiga toxin ( stx) -ve bacteria
Hemolytic Uremic Syndrome (HUS)
Intimin positive ( eae+)
Stx negative bacteria
Hemolytic Uremic Syndrome (HUS)
Stx gene may have been lost during infection mediated by bacteriophage
Hemolytic Uremic Syndrome (HUS)
Shiga toxin ( Stx) inhibits protein synthesis within target cells
Hemolytic Uremic Syndrome (HUS)
Stx could lyse blood cells - hemolytic anemia
Hemolytic Uremic Syndrome (HUS)
Cellular debris accumulates within the boly's tiny blood vessels
Hemolytic Uremic Syndrome (HUS)
Formation of micro clot in the blood vessel rich kidneys leads to impaired kidney function
Hemolytic Uremic Syndrome (HUS)
can cause damage to other major organs
Hemolytic Uremic Syndrome (HUS)
AKA reither's syndrome , post infectious arthritis
Reactive Arthritis ( ReA)
autoimmune disease developed after gastrointestinal and genitourinary infection
Reactive Arthritis ( ReA)
Symptoms: inflammation of joints ( arthritis), conjunctivitis ( eyes), skin, urinary tract ( urethritis)
Reactive Arthritis ( ReA)
symptoms reoccur in 50% of cases
Reactive Arthritis ( ReA)
Treatment: anti inflammatory and pain relieving drugs
Reactive Arthritis ( ReA)
Genetic factor : 60 - 85% patients are HLA B27 positive
Reactive Arthritis ( ReA)
What is HLA
Human Leukocyte antigen
Reactive Arthritis ( ReA)
HLA =?
Human major histocompatibility complex ( MHC)
Reactive Arthritis ( ReA)
cell surface molecules --> tissue typing
Human Leukocyte antigen
Reactive Arthritis ( ReA)
help present antigen at the surface of antigen presenting cell (APC) to T cells
Human Leukocyte antigen
Reactive Arthritis ( ReA)
B27 is?
Subtype of class 1 MHC , B gene
Human Leukocyte antigen
Reactive Arthritis ( ReA)
B27 is strongly associated with?
Spondyloarthritis ( including ReA)
Human Leukocyte antigen
Reactive Arthritis ( ReA)
which 2 factors are required to trigger ReA?
B27 and previous infection
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Which previous infections are they?
Gastrointestinal bacteria
and genitourinary infection
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Gastrointesinal Bacteria
Yersinia, Camplylobacter , Salmonella, Shigella
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Genitourinary Infection (STD)
chlamydia and gonorrhea
Human Leukocyte antigen
Reactive Arthritis ( ReA)
How a distal(2 or more) infection causes ReA?
Hypo 1: presence and persistence of bacterial antigens in the synovial fluid.
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Presence of Viable but non culturable bacteria
Hypo 1
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Presence of immunogenic bacterial antigens
such as Yersinia adhisin YadS, bind specifically to joint collagens
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Bacterial DNA contains un-methylated CpGF motifs, stimulates monocytes
presence of immunogenic bacterial antigens
Human Leukocyte antigen
Reactive Arthritis ( ReA)
Bacterial LPS could stimulate macrophage and cytokineses
presence of immunogenic bacterial antigens
Human Leukocyte antigen
Reactive Arthritis ( ReA)
antigen mimicry leads to autoimmunity
Hypo 2
ReA
What is best studied in Yersinia enterocolitica
T cells, stimulated by pathogen, cross react to self antigen in the joint
Yersinia YopH mimics CD45
mimicry among evolutionarily conserved epitopes, hsp60
Hypo2
ReA
autoimmune disorder affecting peripheral nerve system after gastrointestinal or respiratory infection
Guillain - Barre Syndrome (GBS)
One of the leading cause of acute non trauma induced paralysis in the world
Guillain - Barre Syndrome (GBS)
Symptoms: symmetrical weakness from the lower limbs and rapidly progresses in an ascending fashion.
Guillain - Barre Syndrome (GBS)
rubbery legs, drooling, difficulty swallowing, respiratory difficulty
Guillain - Barre Syndrome (GBS)
Treatment: Supportive care
Intravenous Immunoglobulins
Guillain - Barre Syndrome (GBS)
What is the organisms involved in GBS
campylobacter jejuni
Mechanisms of GBS
T cells stimulate by infection --> attack ganliosides on neuron ..> loss if myelin -- > muscle paralysis
Can myelin regrow
Yes and patient will recover
GBS